Doyle Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Doyle Wealth Management's GILD Position: Q3 2020 in Review
Doyle Wealth Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,856 shares — an estimated $220K sold.
Doyle Wealth Management first reported a position in GILD in Q1 2017 and held it in 14 quarters. The position peaked at $12.3M in Q3 2018. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- Doyle Wealth Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- Doyle Wealth Management sold 2,856 Gilead Sciences shares in Q3 2020, an estimated $220K.
- Doyle Wealth Management first reported a position in Gilead Sciences in Q1 2017 and held it in 14 quarters.
- Doyle Wealth Management's Gilead Sciences position peaked at $12.3M in Q3 2018.
- 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on Doyle Wealth Management's 13F filing for Q3 2020, filed 13 Nov 2020.